$RCEL News

What AVITA Medical Holders Bought Into Before A 347% Run

AVITA Medical to Announce Third Quarter 2026 Financial Results

BTIG Maintains Buy on AVITA Medical, Raises Price Target to $15

AVITA Medical Q2 2026 Earnings Call Transcript

AVITA Medical (RCEL) Stock Sees Fair Value Lift After PermeaDerm Data And Q2 Beat

AVITA Medical, Inc. (RCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy

AVITA Medical (RCEL) Stock Fair Value Rises After PermeaDerm Data And Analyst Target Increases

Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?

AVITA Medical: Favorable Reimbursements For Skin Wound Care

Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft

TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $14

BTIG Maintains Buy on AVITA Medical, Raises Price Target to $11

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

AVITA Medical Announces PermeaDerm-I Study Met Primary Endpoint, Delivering Clinically Comparable Outcomes To Cadaveric Allograft With 70% Cost Reduction

Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%

Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript

AVITA Medical to Host Investor Webinar Briefing